140 related articles for article (PubMed ID: 9205860)
1. Immunodetection of androgen receptor in human urinary bladder cancer.
Zhuang YH; Bläuer M; Tammela T; Tuohimaa P
Histopathology; 1997 Jun; 30(6):556-62. PubMed ID: 9205860
[TBL] [Abstract][Full Text] [Related]
2. Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder.
Chaudhary KS; Lu QL; Abel PD; Khandan-Nia N; Shoma AM; el Baz M; Stamp GW; Lalani EN
Br J Urol; 1997 Jan; 79(1):78-84. PubMed ID: 9043502
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of the proliferating ability and malignant potential of transitional cell carcinoma in the human urinary bladder.
Yoshikawa H; Ikeuchi T; Kai Y
Int J Urol; 1996 Jan; 3(1 Suppl):S32-4. PubMed ID: 24304017
[TBL] [Abstract][Full Text] [Related]
4. Transitional cell carcinoma of the renal pelvis and its expression of p53 protein, c-erbB-2 protein, neuron-specific enolase, Phe 5, chromogranin, laminin and collagen type IV.
Bjerkehagen B; Fosså SD; Raabe N; Holm R; Nesland JM
Eur Urol; 1994; 26(4):334-9. PubMed ID: 7713133
[TBL] [Abstract][Full Text] [Related]
5. p53 immunoreactivity in biopsy specimens of T1G3 transitional cell carcinoma of the bladder--a helpful parameter in guiding the decision for or against cystectomy?
Steiner G; Bierhoff E; Schmidt D; Leissner J; Wolf HK; Albers P
Eur J Cancer; 2000 Mar; 36(5):610-4. PubMed ID: 10738125
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of nuclear p53 protein accumulation in bladder cancer.
Toktaş G; Türkeri LN; Unlüer E; Calişkan M; Aksoy B; Akdaş A
Int Urol Nephrol; 1999; 31(3):327-34. PubMed ID: 10672952
[TBL] [Abstract][Full Text] [Related]
7. Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.
Boorjian SA; Heemers HV; Frank I; Farmer SA; Schmidt LJ; Sebo TJ; Tindall DJ
Endocr Relat Cancer; 2009 Mar; 16(1):123-37. PubMed ID: 18845648
[TBL] [Abstract][Full Text] [Related]
8. Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells.
Zheng Y; Izumi K; Yao JL; Miyamoto H
Endocr Relat Cancer; 2011 Aug; 18(4):451-64. PubMed ID: 21613411
[TBL] [Abstract][Full Text] [Related]
9. Interrelationship between expression of p53, proliferating cell nuclear antigen and c-erbB-2 in bladder cancer.
Lipponen PK
Pathobiology; 1993; 61(3-4):178-82. PubMed ID: 8105802
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer.
Boorjian S; Ugras S; Mongan NP; Gudas LJ; You X; Tickoo SK; Scherr DS
Urology; 2004 Aug; 64(2):383-8. PubMed ID: 15302512
[TBL] [Abstract][Full Text] [Related]
11. Androgen activates β-catenin signaling in bladder cancer cells.
Li Y; Zheng Y; Izumi K; Ishiguro H; Ye B; Li F; Miyamoto H
Endocr Relat Cancer; 2013 Jun; 20(3):293-304. PubMed ID: 23447569
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis.
Izumi K; Zheng Y; Hsu JW; Chang C; Miyamoto H
Mol Carcinog; 2013 Feb; 52(2):94-102. PubMed ID: 22086872
[TBL] [Abstract][Full Text] [Related]
13. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
Tzai TS; Tsai YS; Chow NH
Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
15. Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder.
Miyamoto H; Yao JL; Chaux A; Zheng Y; Hsu I; Izumi K; Chang C; Messing EM; Netto GJ; Yeh S
BJU Int; 2012 Jun; 109(11):1716-26. PubMed ID: 22221549
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of sex-hormone receptor expression in non-muscle-invasive bladder cancer.
Nam JK; Park SW; Lee SD; Chung MK
Yonsei Med J; 2014 Sep; 55(5):1214-21. PubMed ID: 25048477
[TBL] [Abstract][Full Text] [Related]
17. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
[TBL] [Abstract][Full Text] [Related]
18. [The p53 positivity in non-tumor mucosa in patients with superficial urinary bladder cancer].
Soukup V; Babjuk M; Dusková J; Pesl M; Szakácsova M; Zámefnik L; Dvorácek J
Cas Lek Cesk; 2007; 146(1):63-7. PubMed ID: 17310587
[TBL] [Abstract][Full Text] [Related]
19. Expression of retinoblastoma gene product and p53 protein in bladder carcinoma: correlation with Ki67 index.
Wright C; Thomas D; Mellon K; Neal DE; Horne CH
Br J Urol; 1995 Feb; 75(2):173-9. PubMed ID: 7850321
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
